Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Khiron Life Sciences's share price for the quarter that ended in Sep. 2022 was $0.0725. Khiron Life Sciences's Shares Outstanding (EOP) for the quarter that ended in Sep. 2022 was 217.14 Mil. Therefore, Khiron Life Sciences's market cap for the quarter that ended in Sep. 2022 was $15.74 Mil.
Khiron Life Sciences's quarterly market cap
declined
from Mar. 2022 ($36.19 Mil) to Jun. 2022 ($19.63 Mil) and
declined
from Jun. 2022 ($19.63 Mil) to Sep. 2022 ($15.74 Mil).
Khiron Life Sciences's annual market cap
declined
from Dec. 2019 ($94.46 Mil) to Dec. 2020 ($44.64 Mil) and
declined
from Dec. 2020 ($44.64 Mil) to Dec. 2021 ($29.58 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Khiron Life Sciences's Enterprise Value for Today is $2.55 Mil.
Khiron Life Sciences Market Cap Historical Data
The historical data trend for Khiron Life Sciences's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Khiron Life Sciences's Market Cap
For the Drug Manufacturers - Specialty & Generic subindustry, Khiron Life Sciences's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Khiron Life Sciences's Market Cap Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Khiron Life Sciences's Market Cap distribution charts can be found below:
* The bar in red indicates where Khiron Life Sciences's Market Cap falls into.
Khiron Life Sciences Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Khiron Life Sciences's Market Cap for the fiscal year that ended in Dec. 2021 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Khiron Life Sciences (OTCPK:KHRNF) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Khiron Life Sciences Market Cap Related Terms
Thank you for viewing the detailed overview of Khiron Life Sciences's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Khiron Life Sciences (Khiron Life Sciences) Business Description
Khiron Life Sciences Corp is a vertically integrated medical company with core operations in Latin America and Europe, The company's platform leverages medical health clinics and proprietary telemedicine platforms, Khiron combines a patient-oriented approach, physician education programs, scientific, product innovation, and cannabis operations expertise to drive prescriptions and brand loyalty with patients worldwide. The company has a presence in Mexico, Peru, Germany, the United Kingdom, and Brazil.
Khiron Life Sciences (Khiron Life Sciences) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
KHRNF has been successfully added to your 